Latest Breaking News On - Soleno therapeutics company profile - Page 1 : comparemela.com

Soleno Therapeutics (NASDAQ:SLNO) Given New $59 00 Price Target at Oppenheimer

Soleno Therapeutics (NASDAQ:SLNO – Free Report) had its price target cut by Oppenheimer from $65.00 to $59.00 in a research report report published on Monday, Benzinga reports. They currently have an outperform rating on the stock. A number of other research analysts also recently weighed in on SLNO. Stifel Nicolaus assumed coverage on shares of […]

Bhatnagar anishPiper sandlerRobertw bairdStifel nicolausYork mellon corpVivo opportunity llcSoleno therapeutics company profileSilverarc capital managementSoleno therapeutics incSecurities exchange commissionCarlyle group incVivo capitalMaven securitiesSoleno therapeuticsFree reportGet free report

Soleno Therapeutics (NASDAQ:SLNO) Upgraded to Strong-Buy at Baird R W

Soleno Therapeutics (NASDAQ:SLNO) Upgraded to Strong-Buy at Baird R W
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdStifel nicolausPiper sandlerBhatnagar anishSoleno therapeutics company profileCarlyle group incMaven securitiesVivo capitalSoleno therapeutics incYork mellon corpSilverarc capital managementSoleno therapeuticsFree reportGet free reportKristen yenNew york mellon corp

Soleno Therapeutics, Inc (NASDAQ:SLNO) Given Consensus Rating of Buy by Analysts

Soleno Therapeutics, Inc (NASDAQ:SLNO) Given Consensus Rating of Buy by Analysts
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Robertw bairdPiper sandlerStifel nicolausBhatnagar anishVivo opportunity llcVivo capitalSoleno therapeutics company profileCarlyle group incSoleno therapeutics incSecurities exchange commissionSoleno therapeuticsGet free reportVivo opportunityExchange commissionCapital partnersPoint capital

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37 89

Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up to $37 89
theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Stifel nicolausJamesh mackanessPiper sandlerSoleno therapeutics company profileCarlyle group incSoleno therapeutics incVivo capitalSecurities exchange commissionSoleno therapeuticsGet free reportKristen yenExchange commissionCapital partnersPoint capitalCarlyle groupDiazoxide choline extended release

Soleno Therapeutics, Inc (NASDAQ:SLNO) Insider Kristen Yen Sells 2,218 Shares

Soleno Therapeutics, Inc. (NASDAQ:SLNO – Get Free Report) insider Kristen Yen sold 2,218 shares of the stock in a transaction dated Monday, April 1st. The stock was sold at an average price of $41.34, for a total transaction of $91,692.12. Following the transaction, the insider now directly owns 23,422 shares in the company, valued at […]

Stifel nicolausPiper sandlerCarlyle group incSoleno therapeutics incNantahala capital managementVivo capitalWorth venture partnersPerceptive advisorsSoleno therapeutics company profileSoleno therapeuticsGet free reportKristen yenCapital managementDiazoxide choline extended releaseSoleno therapeutics dailyNasdaq slno